Lv4
590 积分 2021-12-10 加入
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation
1天前
已完结
Efficacy and safety analysis of Dupilumab for atopic dermatitis of all ages in Chinese population: Real‐world data from a single center
6天前
已完结
Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe
7天前
已完结
The cardiometabolic safety of dupilumab in atopic dermatitis: A global large-scale cohort study
2个月前
已完结
Effect of dupilumab on asthma and aeroallergen sensitization in pediatric atopic dermatitis patients: Results of the BioDay registry
5个月前
已完结
Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients
6个月前
已完结
Reactive perforating collagenosis treated with dupilumab: A case report and literature review
7个月前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
7个月前
已完结
The real‐world, long‐term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study
8个月前
已完结
皖公网安备34019202002308
